Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle (SEMINOMES)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Patricia FAUQUE
- Phone Number: +33 03.80.29.50. 31
- Email: Patricia.fauque@chu-dijon.fr
Study Locations
-
-
-
Dijon, France, 21079
- Recruiting
- CHU Dijon Bourgogne
-
Contact:
- Patricia FAUQUE
- Phone Number: +33 03.80.29.50. 31
- Email: Patricia.fauque@chu-dijon.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- men who have provided oral consent
- men with germinal testicular cancer with negative or low serum markers (Alpha Foeto Protein AFP and Human Chorionic Gonadotrophin hCG), indicators of a seminomatous-type tumour
- men who have undergone orchiectomy (total excision of the affected testicle)
- confirmation of the diagnosis of seminomatous or non-seminomatous type by histology of the surgical piece
- absence of hepatitis B or C or infection with human immunodeficiency virus (HIV).
Exclusion Criteria:
- men without national health insurance cover
- Adults under guardianship
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
7/8 cases pure seminomas
|
|
|
5 cases of non-seminoma
|
|
|
3 cases of composite tumours seminoma/non-seminoma.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The role of Transposable Element in tumorigenesis seminomas adults
Time Frame: through the study completion up to 36 months
|
Transcriptomic analysis of adult seminomas
|
through the study completion up to 36 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- FAUQUE 2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.